On the public citation graph

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

https://doi.org/10.1126/sciadv.abc9450
0 signed · 658 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/adma.201906128openalex-snapshot
A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes
inferredcites →https://doi.org/10.1002/biot.201400046openalex-snapshot
CRISPR/Cas9‐mediated genome engineering: An adeno‐associated viral (AAV) vector toolbox
inferredcites →https://doi.org/10.1002/cncr.2820710423openalex-snapshot
Intraperitoneal chemotherapy in the management of ovarian cancer
inferredcites →https://doi.org/10.1007/s11060-015-1875-1openalex-snapshot
Current status of intratumoral therapy for glioblastoma
inferredcites →https://doi.org/10.1007/s11060-018-2747-2openalex-snapshot
Localized targeted antiangiogenic drug delivery for glioblastoma
inferredcites →https://doi.org/10.1016/j.addr.2019.11.005openalex-snapshot
Rational designs of in vivo CRISPR-Cas delivery systems
inferredcites →https://doi.org/10.1016/j.biomaterials.2016.09.006openalex-snapshot
Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
inferredcites →https://doi.org/10.1016/j.cell.2014.05.010openalex-snapshot
Development and Applications of CRISPR-Cas9 for Genome Engineering
inferredcites →https://doi.org/10.1016/j.celrep.2018.02.014openalex-snapshot
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
inferredcites →https://doi.org/10.1016/j.jbiotec.2015.04.024openalex-snapshot
Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection
inferredcites →https://doi.org/10.1016/j.jtbi.2014.02.025openalex-snapshot
Evolution of acquired resistance to anti-cancer therapy
inferredcites →https://doi.org/10.1016/j.jtbi.2018.06.014openalex-snapshot
What does not kill a tumour may make it stronger: In silico insights into chemotherapeutic drug resistance
inferredcites →https://doi.org/10.1016/j.omtm.2018.06.006openalex-snapshot
Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
inferredcites →https://doi.org/10.1016/j.omto.2018.12.003openalex-snapshot
Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer
inferredcites →https://doi.org/10.1016/j.smim.2017.08.015openalex-snapshot
Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics—An innate immune system standpoint
inferredcites →https://doi.org/10.1016/j.soncn.2019.02.001openalex-snapshot
Ovarian Cancer: An Integrated Review
inferredcites →https://doi.org/10.1021/acs.accounts.9b00106openalex-snapshot
Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
inferredcites →https://doi.org/10.1021/acs.bioconjchem.7b00057openalex-snapshot
In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges
inferredcites →https://doi.org/10.1021/acs.nanolett.6b03329openalex-snapshot
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
inferredcites →https://doi.org/10.1038/am.2017.185openalex-snapshot
Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapy
inferredcites →https://doi.org/10.1038/nature10177openalex-snapshot
In vivo genome editing restores haemostasis in a mouse model of haemophilia
inferredcites →https://doi.org/10.1038/nature14592openalex-snapshot
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
inferredcites →https://doi.org/10.1038/nature16526openalex-snapshot
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
inferredcites →https://doi.org/10.1038/nbt.2623openalex-snapshot
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
inferredcites →https://doi.org/10.1038/nbt.2884openalex-snapshot
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
inferredcites →https://doi.org/10.1038/nbt.3471openalex-snapshot
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
inferredcites →https://doi.org/10.1038/nm.1863openalex-snapshot
Development of a novel mouse glioma model using lentiviral vectors
inferredcites →https://doi.org/10.1038/s41419-020-2571-4openalex-snapshot
Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease
inferredcites →https://doi.org/10.1038/s41467-018-06936-1openalex-snapshot
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
inferredcites →https://doi.org/10.1038/s41467-019-12281-8openalex-snapshot
Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning
inferredcites →https://doi.org/10.1038/s41565-017-0043-5openalex-snapshot
A modular platform for targeted RNAi therapeutics
inferredcites →https://doi.org/10.1038/s41565-020-0669-6openalex-snapshot
Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
inferredcites →https://doi.org/10.1038/s41591-018-0137-0openalex-snapshot
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
inferredcites →https://doi.org/10.1038/s41598-019-41941-4openalex-snapshot
Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas
inferredcites →https://doi.org/10.1080/1061186x.2016.1221955openalex-snapshot
Pieter Cullis’ quest for a lipid-based, fusogenic delivery system for nucleic acid therapeutics: success with siRNA so what about mRNA?
inferredcites →https://doi.org/10.1080/17425247.2016.1200557openalex-snapshot
Harnessing nanomedicine for therapeutic intervention in glioblastoma
inferredcites →https://doi.org/10.1089/nat.2018.0734openalex-snapshot
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
inferredcites →https://doi.org/10.1097/igc.0b013e318234f833openalex-snapshot
Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian Cancer Is Feasible With High Completion Rates, Low Complications, and Acceptable Patient Outcomes
inferredcites →https://doi.org/10.1101/gr.171322.113openalex-snapshot
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
inferredcites →https://doi.org/10.1126/sciadv.1501292openalex-snapshot
Targeting NF-κB in glioblastoma: A therapeutic approach
inferredcites →https://doi.org/10.1126/science.1254445openalex-snapshot
Prevention of muscular dystrophy in mice by CRISPR/Cas9–mediated editing of germline DNA
inferredcites →https://doi.org/10.1126/science.aad5227openalex-snapshot
Rationally engineered Cas9 nucleases with improved specificity
inferredcites →https://doi.org/10.1126/science.aad5725openalex-snapshot
Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
inferredcites →https://doi.org/10.1146/annurev-chembioeng-080615-034711openalex-snapshot
Engineering Delivery Vehicles for Genome Editing
inferredcites →https://doi.org/10.1261/rna.071704.119openalex-snapshot
Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins
inferredcites →https://doi.org/10.1369/0022155411410885openalex-snapshot
Biodistribution of Small Interfering RNA at the Organ and Cellular Levels after Lipid Nanoparticle-mediated Delivery
inferredcites →https://doi.org/10.3322/caac.21559openalex-snapshot
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
inferredcites →https://doi.org/10.3390/cancers10090296openalex-snapshot
Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
inferredcites →https://doi.org/10.4049/jimmunol.1500804openalex-snapshot
Adaptive Immunity against Streptococcus pyogenes in Adults Involves Increased IFN-γ and IgG3 Responses Compared with Children

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4657914openalex-extracted
Delivery of Rna Drugs: Beyond the Liver, More than Vaccine
inferred← citeshttps://doi.org/10.1002/9781394175635.ch6openalex-snapshot
Nanoparticles for Tumor Gene Therapy
inferred← citeshttps://doi.org/10.1002/9781394175635.ch9openalex-snapshot
Nanoparticles as Gene Vectors in Tumor Therapy
inferred← citeshttps://doi.org/10.1002/9781394209156.ch9openalex-snapshot
The Evolution of Genome‐Editing Technologies
inferred← citeshttps://doi.org/10.1002/9781394236145.ch20openalex-snapshot
Drug Delivery Modalities and Mechanisms
inferred← citeshttps://doi.org/10.1002/adfm.202413233openalex-snapshot
Two‐Step Targeting‐Tunable Semiconducting Nanoswitches Amplify Mitochondrion Damage and PD‐L1 Blockade for Orthotopic Pancreatic Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adfm.202416285openalex-snapshot
Microneedle‐Loaded Gene‐Editable Nanohybrids Engineer Cancer Cells by Telomere Stress Induction and Metabolic Interference for Enhanced Cuproptosis and Immunotherapy
inferred← citeshttps://doi.org/10.1002/adfm.77082openalex-snapshot
Electrostatically‐Stabilized PEG‐Free Lipid Nanoparticles for Systemic Nucleic Acid Delivery
inferred← citeshttps://doi.org/10.1002/adhm.202100847openalex-snapshot
The Delivery Challenge of Genome Editing in Human Epithelia
inferred← citeshttps://doi.org/10.1002/adhm.202201825openalex-snapshot
Enhancement of Gene Editing and Base Editing with Therapeutic Ribonucleoproteins through In Vivo Delivery Based on Absorptive Silica Nanoconstruct
inferred← citeshttps://doi.org/10.1002/adhm.202202155openalex-snapshot
Multi‐Targeting Nano‐Systems Targeting Heterogeneous Cancer Cells for Therapeutics and Biomarker Detection
inferred← citeshttps://doi.org/10.1002/adhm.202202400openalex-snapshot
Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases
inferred← citeshttps://doi.org/10.1002/adhm.202302902openalex-snapshot
Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment
inferred← citeshttps://doi.org/10.1002/adhm.202404781openalex-snapshot
Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy
inferred← citeshttps://doi.org/10.1002/adma.202104641openalex-snapshot
Sono‐Controllable and ROS‐Sensitive CRISPR‐Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy
inferred← citeshttps://doi.org/10.1002/adma.202106350openalex-snapshot
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
inferred← citeshttps://doi.org/10.1002/adma.202107946openalex-snapshot
Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines
inferred← citeshttps://doi.org/10.1002/adma.202110560openalex-snapshot
Endocytosis‐Independent and Cancer‐Selective Cytosolic Protein Delivery via Reversible Tagging with LAT1 substrate
inferred← citeshttps://doi.org/10.1002/adma.202207471openalex-snapshot
An Integrated Polymeric mRNA Vaccine without Inflammation Side Effects for Cellular Immunity Mediated Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adma.202300665openalex-snapshot
Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adma.202303261openalex-snapshot
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adma.202307822openalex-snapshot
Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery
inferred← citeshttps://doi.org/10.1002/adma.202308029openalex-snapshot
Engineered mRNA Delivery Systems for Biomedical Applications
inferred← citeshttps://doi.org/10.1002/adma.202309225openalex-snapshot
Nanoparticle‐Mediated Delivery of Anti‐PU.1 siRNA via Localized Intracisternal Administration Reduces Neuroinflammation
inferred← citeshttps://doi.org/10.1002/adma.202312559openalex-snapshot
Injectable Microgels with Hybrid Exosomes of Chondrocyte‐Targeted FGF18 Gene‐Editing and Self‐Renewable Lubrication for Osteoarthritis Therapy
inferred← citeshttps://doi.org/10.1002/adma.202522618openalex-snapshot
High‐Entropy Alloy Synergized with Gene Editing for Cocktail‐Sensitized Radioimmunotherapy of Lung Metastases
inferred← citeshttps://doi.org/10.1002/adma.73984openalex-snapshot
Resolving Heterogeneity of Targeted Lipid Nanoparticles Through Solution‐Based Biophysical Analyses
inferred← citeshttps://doi.org/10.1002/adma.74760openalex-snapshot
Advanced Materials for Biologics Delivery to Brain Tumors
inferred← citeshttps://doi.org/10.1002/adtp.202200287openalex-snapshot
DNA Nanogel for Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adtp.202500395openalex-snapshot
Aptamer‐Guided CRISPR Systems Delivery: Precision Targeting Strategies, Translational Barriers, and Therapeutic Potential
inferred← citeshttps://doi.org/10.1002/advs.202102072openalex-snapshot
Together is Better: mRNA Co‐Encapsulation in Lipoplexes is Required to Obtain Ratiometric Co‐Delivery and Protein Expression on the Single Cell Level
inferred← citeshttps://doi.org/10.1002/advs.202201740openalex-snapshot
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
inferred← citeshttps://doi.org/10.1002/advs.202202797openalex-snapshot
Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
inferred← citeshttps://doi.org/10.1002/advs.202207512openalex-snapshot
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
inferred← citeshttps://doi.org/10.1002/advs.202301929openalex-snapshot
A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery
inferred← citeshttps://doi.org/10.1002/advs.202308763openalex-snapshot
An Antibody‐CRISPR/Cas Conjugate Platform for Target‐Specific Delivery and Gene Editing in Cancer
inferred← citeshttps://doi.org/10.1002/advs.202309004openalex-snapshot
Library‐Assisted Evolution in Eukaryotic Cells Yield Adenine Base Editors with Enhanced Editing Specificity
inferred← citeshttps://doi.org/10.1002/advs.202309917openalex-snapshot
Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy
inferred← citeshttps://doi.org/10.1002/advs.202400493openalex-snapshot
Lipid Nanoparticle‐Mediated Delivery of CRISPR‐Cas9 Against Rubicon Ameliorates NAFLD by Modulating CD36 Along with Glycerophospholipid Metabolism
inferred← citeshttps://doi.org/10.1002/advs.202411032openalex-snapshot
Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer
inferred← citeshttps://doi.org/10.1002/advs.202414559openalex-snapshot
Therapeutic Delivery of circDYM by Perillyl Alcohol Nanoemulsion Alleviates LPS‐Induced Depressive‐Like Behaviors
inferred← citeshttps://doi.org/10.1002/advs.202417571openalex-snapshot
Recent Advances in mRNA Delivery Systems for Cancer Therapy
inferred← citeshttps://doi.org/10.1002/advs.202503725openalex-snapshot
CRISPRa Lipid Nanocomplex‐Mediated Mt3 Targeting Enhances Astrocytic Endocytosis of Amyloid‐β in an Alzheimer's Disease Mouse Model
inferred← citeshttps://doi.org/10.1002/advs.202511222openalex-snapshot
Unique Aerofoil‐Structured Microfluidics for High Throughput Lipid Nanoparticle Formulation Screening and Scale‐up
inferred← citeshttps://doi.org/10.1002/advs.75837openalex-snapshot
Nucleic Acid Therapeutics for “Undruggable” Cancer Targets: Mechanisms, Challenges, and Prospects
inferred← citeshttps://doi.org/10.1002/anbr.202100109openalex-snapshot
Lipid Nanoparticles for Drug Delivery
inferred← citeshttps://doi.org/10.1002/anbr.202200082openalex-snapshot
Nonviral Delivery of CRISPR/Cas Systems in mRNA Format
inferred← citeshttps://doi.org/10.1002/anbr.202300006openalex-snapshot
Ionizable Lipid Nanoparticles for mRNA Delivery
inferred← citeshttps://doi.org/10.1002/ange.202506954openalex-snapshot
Thioamides Adjacent to the Ionizable Amine Headgroup in Ionizable Lipids Reduce the p K a of Lipid Nanoparticles and Enhance mRNA Transfection Efficiency in Vitro and in Vivo
inferred← citeshttps://doi.org/10.1002/ange.4386021openalex-snapshot
A Self‐Monitoring Single‐Atom Copper Nanocapsule for Cascade‐Responsive Tumor Cuproptosis Therapy
inferred← citeshttps://doi.org/10.1002/anie.202506954openalex-snapshot
Thioamides Adjacent to the Ionizable Amine Headgroup in Ionizable Lipids Reduce the p K a of Lipid Nanoparticles and Enhance mRNA Transfection Efficiency in Vitro and in Vivo
inferred← citeshttps://doi.org/10.1002/anie.4386021openalex-snapshot
A Self‐Monitoring Single‐Atom Copper Nanocapsule for Cascade‐Responsive Tumor Cuproptosis Therapy
inferred← citeshttps://doi.org/10.1002/bkcs.70083openalex-snapshot
Delivery strategies of messenger RNA therapeutics for brain disorders
inferred← citeshttps://doi.org/10.1002/btm2.10213openalex-snapshot
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
inferred← citeshttps://doi.org/10.1002/btm2.10492openalex-snapshot
Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities
inferred← citeshttps://doi.org/10.1002/cac2.12194openalex-snapshot
The role of non‐coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential
inferred← citeshttps://doi.org/10.1002/cac2.12366openalex-snapshot
Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management
inferred← citeshttps://doi.org/10.1002/cam4.70921openalex-snapshot
Strategies Beyond 3rd EGFR‐TKI Acquired Resistance: Opportunities and Challenges
inferred← citeshttps://doi.org/10.1002/cbf.3954openalex-snapshot
Recent advances in mRNA‐based vaccine for cancer therapy; bench to bedside
inferred← citeshttps://doi.org/10.1002/cbic.202200801openalex-snapshot
Intracellular Delivery of mRNA for Cell‐Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles
inferred← citeshttps://doi.org/10.1002/cmdc.202300647openalex-snapshot
Nano‐Engineering Strategies for Tumor‐Specific Therapy
inferred← citeshttps://doi.org/10.1002/ctm2.1382openalex-snapshot
Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells
inferred← citeshttps://doi.org/10.1002/dvg.23598openalex-snapshot
CRISPR‐Cas9 delivery strategies and applications: Review and update
inferred← citeshttps://doi.org/10.1002/elps.202300106openalex-snapshot
Scalable multimodal weak anion exchange chromatographic purification for stable mRNA drug substance
inferred← citeshttps://doi.org/10.1002/exp.20210081openalex-snapshot
Carrier strategies boost the application of CRISPR/Cas system in gene therapy
inferred← citeshttps://doi.org/10.1002/imt2.70067openalex-snapshot
RRM2‐targeted nanocarrier enhances radiofrequency ablation efficacy in hepatocellular carcinoma through ferroptosis amplification and immune remodeling
inferred← citeshttps://doi.org/10.1002/jev2.70130openalex-snapshot
124 I‐labelled BMSC‐Derived Extracellular Vesicles Deliver CRISPR/Cas9 Ribonucleoproteins With a GFP‐Reporter System to Inhibit Osteosarcoma Proliferation and Metastasis
inferred← citeshttps://doi.org/10.1002/mba2.10openalex-snapshot
Nonviral vector system for cancer immunogene therapy
inferred← citeshttps://doi.org/10.1002/mba2.70openalex-snapshot
Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
inferred← citeshttps://doi.org/10.1002/mco2.155openalex-snapshot
Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives
inferred← citeshttps://doi.org/10.1002/mco2.339openalex-snapshot
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/mco2.645openalex-snapshot
Current developments of gene therapy in human diseases
inferred← citeshttps://doi.org/10.1002/mco2.70414openalex-snapshot
Design Strategies for Novel Lipid Nanoparticle for mRNA Vaccine and Therapeutics: Current Understandings and Future Perspectives
inferred← citeshttps://doi.org/10.1002/mco2.70700openalex-snapshot
mRNA Lipid Nanoparticles for Cell Engineering in Vivo and in Vitro: Current Applications and Future Directions
inferred← citeshttps://doi.org/10.1002/mco2.767openalex-snapshot
Nanomedicine for cancer patient‐centered care
inferred← citeshttps://doi.org/10.1002/mog2.70044openalex-snapshot
Parkinson's Disease and Cancer: Mechanistic Insights and Therapeutic Opportunities From Cancer Neuroscience
inferred← citeshttps://doi.org/10.1002/mog2.70084openalex-snapshot
Nanoparticle‐Mediated Therapy for Glioma: Advances and Prospects
inferred← citeshttps://doi.org/10.1002/smll.202100287openalex-snapshot
Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian Cancer
inferred← citeshttps://doi.org/10.1002/smll.202310531openalex-snapshot
Lipid Nanocarrier‐Based mRNA Therapy: Challenges and Promise for Clinical Transformation
inferred← citeshttps://doi.org/10.1002/smll.202409353openalex-snapshot
Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing
inferred← citeshttps://doi.org/10.1002/smll.202409635openalex-snapshot
Antibody‐Nanoparticle Conjugates in Therapy: Combining the Best of Two Worlds
inferred← citeshttps://doi.org/10.1002/smll.202506812openalex-snapshot
Recent Advances in Lipid Nanoparticles: Nucleic Acid Therapeutics and Targeting Strategies
inferred← citeshttps://doi.org/10.1002/smll.75388openalex-snapshot
Efficient Colon Cancer Immunogene Therapy by Hydrogel Ball Loaded With Two Types of Cell Membrane‐Coated Nanoparticles
inferred← citeshttps://doi.org/10.1002/smsc.202400192openalex-snapshot
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing
inferred← citeshttps://doi.org/10.1002/smtd.202401632openalex-snapshot
Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components
inferred← citeshttps://doi.org/10.1002/wnan.1894openalex-snapshot
The clinical progress and challenges of mRNA vaccines
inferred← citeshttps://doi.org/10.1002/wnan.1938openalex-snapshot
CRISPR /Cas gene editing and delivery systems for cancer therapy
inferred← citeshttps://doi.org/10.1002/wnan.1996openalex-snapshot
Nanomedicine Therapies for Pediatric Diseases
inferred← citeshttps://doi.org/10.1007/164_2024_723openalex-snapshot
Reaching Outer Space and Enabling the mRNA Revolution: A Critical Role of Partnerships for Successful Drug and Vaccine Development
inferred← citeshttps://doi.org/10.1007/16833_2024_404openalex-snapshot
Implementing CRISPR/Cas9 into the Study of Anticancer Drug Resistance
inferred← citeshttps://doi.org/10.1007/978-1-0716-2573-6_7openalex-snapshot
Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next-Generation Sequencing Data
inferred← citeshttps://doi.org/10.1007/978-1-0716-3890-3_21openalex-snapshot
RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens
inferred← citeshttps://doi.org/10.1007/978-1-0716-4554-3_17openalex-snapshot
Drug Delivery to the Reproductive System: Innovations and Therapeutic Advances
inferred← citeshttps://doi.org/10.1007/978-3-030-80108-3_2openalex-snapshot
Biotechnology of Twenty-First Century
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_292-1openalex-snapshot
Turning Tables for CRISPR/Cas9 Editing System: From Scratch to Advanced Delivery Platforms
inferred← citeshttps://doi.org/10.1007/978-3-031-08415-7_5openalex-snapshot
Medical Use of mRNA-Based Directed Gene Delivery
inferred← citeshttps://doi.org/10.1007/978-3-031-62007-2_10openalex-snapshot
CRISPR Technology and Its Application in Therapeutics
inferred← citeshttps://doi.org/10.1007/978-3-032-00765-0_292openalex-snapshot
Turning Tables for CRISPR/Cas9 Editing System: From Scratch to Advanced Delivery Platforms
inferred← citeshttps://doi.org/10.1007/978-3-032-16316-5_17openalex-snapshot
Nanoparticle Designs for Specific Targeting in Precision Theranostics
inferred← citeshttps://doi.org/10.1007/978-3-662-67908-1openalex-snapshot
Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft
inferred← citeshttps://doi.org/10.1007/978-3-662-67908-1_6openalex-snapshot
Nichtvirale Vektoren
inferred← citeshttps://doi.org/10.1007/978-981-19-5642-3_10openalex-snapshot
Genome Editing in Dyslipidemia and Atherosclerosis
inferred← citeshttps://doi.org/10.1007/s00018-023-04852-2openalex-snapshot
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy
inferred← citeshttps://doi.org/10.1007/s00203-026-04988-2openalex-snapshot
CRISPR-based gene editing for antimicrobial resistance control in human medicine
inferred← citeshttps://doi.org/10.1007/s10142-025-01712-zopenalex-snapshot
Cancer gene therapy: historical perspectives, current applications, and future directions
inferred← citeshttps://doi.org/10.1007/s10238-025-01686-zopenalex-snapshot
Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation
inferred← citeshttps://doi.org/10.1007/s10528-026-11378-2openalex-snapshot
Next-Generation Therapies for Genetic Diseases: The Synergy of CRISPR and Gene Therapy
inferred← citeshttps://doi.org/10.1007/s10555-025-10243-9openalex-snapshot
Advancements in gene therapies targeting mutant KRAS in cancers
inferred← citeshttps://doi.org/10.1007/s10565-024-09907-zopenalex-snapshot
Let’s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment
inferred← citeshttps://doi.org/10.1007/s11051-023-05693-7openalex-snapshot
Zero to zero nanoarchitectonics with fullerene: from molecules to nanoparticles
inferred← citeshttps://doi.org/10.1007/s11060-026-05500-yopenalex-snapshot
MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy
inferred← citeshttps://doi.org/10.1007/s11154-026-10022-zopenalex-snapshot
Hypothalamic wars: the last nanodelivery
inferred← citeshttps://doi.org/10.1007/s11356-024-32101-xopenalex-snapshot
Nanomaterials for intelligent CRISPR-Cas tools: improving environment sustainability
inferred← citeshttps://doi.org/10.1007/s11426-022-1376-1openalex-snapshot
Responsive MXene nanovehicles deliver CRISPR/Cas12a for boolean logic-controlled gene editing
inferred← citeshttps://doi.org/10.1007/s11426-023-1708-3openalex-snapshot
Traceless photodegradable polymer cocoons for universal protein delivery and light-controlled gene editing
inferred← citeshttps://doi.org/10.1007/s12032-025-02939-3openalex-snapshot
Lipid nanoparticles: a promising tool for nucleic acid delivery in cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s12247-026-10876-5openalex-snapshot
Lipid Nanoparticles Based Drug Delivery Systems: Design Innovations, Therapeutic Applications, and Translational Progress
inferred← citeshttps://doi.org/10.1007/s12274-024-6748-5openalex-snapshot
Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing
inferred← citeshttps://doi.org/10.1007/s12668-025-02094-zopenalex-snapshot
CRISPR-Cas9-Loaded Lipid Nanoparticles: A Promising Strategy for Targeted Gene Editing and Therapy
inferred← citeshttps://doi.org/10.1007/s12672-022-00509-xopenalex-snapshot
Understanding on CRISPR/Cas9 mediated cutting-edge approaches for cancer therapeutics
inferred← citeshttps://doi.org/10.1007/s13205-024-04186-1openalex-snapshot
Improving the use of CRISPR/Cas9 gene editing machinery as a cancer therapeutic tool with the help of nanomedicine
inferred← citeshttps://doi.org/10.1007/s13346-026-02044-6openalex-snapshot
The RNA delivery dilemma—lipid versus polymer nanoparticle platforms
inferred← citeshttps://doi.org/10.1007/s13534-021-00199-4openalex-snapshot
Challenges in delivery systems for CRISPR-based genome editing and opportunities of nanomedicine
inferred← citeshttps://doi.org/10.1007/s40291-024-00705-1openalex-snapshot
In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia
inferred← citeshttps://doi.org/10.1007/s40843-024-2855-2openalex-snapshot
Nanomaterials boost the biomedical application of synthetic biology
inferred← citeshttps://doi.org/10.1016/b978-0-12-822425-0.00096-8openalex-snapshot
Lipid nanoparticles for delivery of gene editing components
inferred← citeshttps://doi.org/10.1016/b978-0-12-824273-5.00004-0openalex-snapshot
Strategies to overcome interleukin-1-mediated immune suppression and resistance to immunotherapy in cancer
inferred← citeshttps://doi.org/10.1016/b978-0-323-88450-1.00016-8openalex-snapshot
Nanotechnology based gene delivery strategies towards disease therapy; advances and applications
inferred← citeshttps://doi.org/10.1016/b978-0-323-91009-5.00028-8openalex-snapshot
Current status and future prospects of nanoparticles as plant genetic materials carrier
inferred← citeshttps://doi.org/10.1016/b978-0-323-91195-5.00003-9openalex-snapshot
Harnessing biomedical applications of bionanomaterials through omics approach
inferred← citeshttps://doi.org/10.1016/b978-0-443-14064-8.00047-3openalex-snapshot
Novel approaches to immuno-oncology
inferred← citeshttps://doi.org/10.1016/b978-0-443-15491-1.00012-2openalex-snapshot
Liposomes as DNA, mRNA and oligonucleotide delivery vectors
inferred← citeshttps://doi.org/10.1016/b978-0-443-23865-9.00003-4openalex-snapshot
Applications of CRISPR technology
inferred← citeshttps://doi.org/10.1016/b978-0-443-26761-1.00004-1openalex-snapshot
Nanomedicine in cancer diagnosis and treatment
inferred← citeshttps://doi.org/10.1016/b978-0-443-27414-5.00002-6openalex-snapshot
Applying innovative genome editing technologies (e.g., CRISPR/Cas9 systems) in stem cell engineering and neurological disorders and diseases
inferred← citeshttps://doi.org/10.1016/b978-0-443-30016-5.00007-0openalex-snapshot
Introduction to nanogels: exploring the frontier of nanoscale technology
inferred← citeshttps://doi.org/10.1016/b978-0-443-31592-3.00005-4openalex-snapshot
Investigating the potential of CRISPR-Cas9 gene editing technology for gene therapy in cancer
inferred← citeshttps://doi.org/10.1016/b978-0-443-44579-8.00001-1openalex-snapshot
Crossing the barrier, crossing the line: neurotoxicity of nanomedicines in brain cancer therapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-45006-8.00014-8openalex-snapshot
Future trends in LNP-mRNA therapeutics
inferred← citeshttps://doi.org/10.1016/bs.ai.2024.10.009openalex-snapshot
Nucleic acid delivery as a therapeutic approach for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/bs.ircmb.2022.04.007openalex-snapshot
mRNA-based therapies: Preclinical and clinical applications
inferred← citeshttps://doi.org/10.1016/bs.ircmb.2023.06.003openalex-snapshot
Epigenetic inhibitors for cancer treatment
inferred← citeshttps://doi.org/10.1016/j.addr.2021.113891openalex-snapshot
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
inferred← citeshttps://doi.org/10.1016/j.addr.2021.113907openalex-snapshot
Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics
inferred← citeshttps://doi.org/10.1016/j.addr.2021.113930openalex-snapshot
Advances in mRNA non-viral delivery approaches
inferred← citeshttps://doi.org/10.1016/j.addr.2021.114042openalex-snapshot
Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114197openalex-snapshot
Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids
inferred← citeshttps://doi.org/10.1016/j.addr.2023.114861openalex-snapshot
Lipid nanoparticle-mediated drug delivery to the brain
inferred← citeshttps://doi.org/10.1016/j.addr.2023.114990openalex-snapshot
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
inferred← citeshttps://doi.org/10.1016/j.addr.2023.114993openalex-snapshot
mRNA: A promising platform for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.addr.2023.115026openalex-snapshot
Gene editing therapeutics based on mRNA delivery
inferred← citeshttps://doi.org/10.1016/j.addr.2024.115359openalex-snapshot
Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications
inferred← citeshttps://doi.org/10.1016/j.addr.2025.115606openalex-snapshot
Nanomedicine for targeting brain Neurodegeneration: Critical barriers and circadian rhythm Considerations
inferred← citeshttps://doi.org/10.1016/j.addr.2025.115619openalex-snapshot
CRISPR/Cas bioimaging: From whole body biodistribution to single-cell dynamics
inferred← citeshttps://doi.org/10.1016/j.addr.2025.115759openalex-snapshot
Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma
inferred← citeshttps://doi.org/10.1016/j.ajps.2023.100854openalex-snapshot
CRISPR/Cas9 systems: Delivery technologies and biomedical applications
inferred← citeshttps://doi.org/10.1016/j.apsb.2021.05.020openalex-snapshot
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
inferred← citeshttps://doi.org/10.1016/j.apsb.2022.12.013openalex-snapshot
Intelligent nanotherapeutic strategies for the delivery of CRISPR system
inferred← citeshttps://doi.org/10.1016/j.apsb.2023.03.001openalex-snapshot
mRNA delivery in cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.apsb.2024.08.030openalex-snapshot
Optimized lipid nanoparticles enable effective CRISPR/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy
inferred← citeshttps://doi.org/10.1016/j.apsb.2025.05.007openalex-snapshot
Advancements in CRISPR/Cas systems for disease treatment
inferred← citeshttps://doi.org/10.1016/j.apsb.2025.10.002openalex-snapshot
The progress and perspective of nanomedicine in modulating the tumor immune microenvironment
inferred← citeshttps://doi.org/10.1016/j.apsb.2025.10.015openalex-snapshot
From single-thread delivery to cascading therapy: The promise of nanoCRISPR in solid tumors
inferred← citeshttps://doi.org/10.1016/j.apsb.2025.11.023openalex-snapshot
Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution
inferred← citeshttps://doi.org/10.1016/j.bbcan.2023.188997openalex-snapshot
Tumor microenvironment diversity and plasticity in cancer multidrug resistance
inferred← citeshttps://doi.org/10.1016/j.bbcan.2025.189480openalex-snapshot
Nanoparticulate delivery and targeting of RNA to the brain
inferred← citeshttps://doi.org/10.1016/j.bbcan.2026.189592openalex-snapshot
Emerging advantages of nano delivery systems in enhancing CAR-T/CRISPR-Cas9 mediated cancer therapeutics
inferred← citeshttps://doi.org/10.1016/j.bbrc.2025.152512openalex-snapshot
RNA drugs and nonviral nanocarriers in oncology – present status and emerging concepts
inferred← citeshttps://doi.org/10.1016/j.bbrc.2026.153719openalex-snapshot
CRISPR-mediated regulation of apoptosis in cancer: Molecular targets, mechanisms, and translational challenges
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2021.05.051openalex-snapshot
Ionizable lipid-assisted efficient hepatic delivery of gene editing elements for oncotherapy
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2022.08.013openalex-snapshot
Genome editing in cancer: Challenges and potential opportunities
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2022.09.026openalex-snapshot
“Genetic scissors” CRISPR/Cas9 genome editing cutting-edge biocarrier technology for bone and cartilage repair
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2025.08.016openalex-snapshot
Nanotechnology strategies for endometrium health: Are we on the right track?
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2022.121876openalex-snapshot
In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2023.122158openalex-snapshot
Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2024.122559openalex-snapshot
Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2025.123830openalex-snapshot
Injectable CRISPRa-microspheres for targeted A20 activation rescue age-related osteogenic impairment via senescence mitigation
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2026.124333openalex-snapshot
Dual-functional poly(disulfide) enables “Once-and-for-all” atherosclerosis therapy via precision hepatocyte base editing
inferred← citeshttps://doi.org/10.1016/j.biopha.2026.119398openalex-snapshot
Diverse structures and shapes of lipid-based nanoparticles: Toward clinical translation
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2026.108862openalex-snapshot
RNA therapeutics 2.0: Expanding the landscape from mRNA vaccines to splicing modulators and beyond
inferred← citeshttps://doi.org/10.1016/j.bulcan.2025.03.007openalex-snapshot
Epigenetic reprogramming in breast cancer: The role of CRISPR-Cas 9
inferred← citeshttps://doi.org/10.1016/j.carbpol.2023.120695openalex-snapshot
A multi-bioresponsive self-assembled nano drug delivery system based on hyaluronic acid and geraniol against liver cancer
inferred← citeshttps://doi.org/10.1016/j.ccr.2025.216945openalex-snapshot
Nanomaterials-enabled mRNA delivery for Cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.cej.2022.135116openalex-snapshot
Non-viral nanocarriers for CRISPR-Cas9 gene editing system delivery
inferred← citeshttps://doi.org/10.1016/j.cej.2025.165897openalex-snapshot
“Zombie” cell drug delivery system: A novel strategy for the treatment of cancer and inflammation-related diseases
inferred← citeshttps://doi.org/10.1016/j.cell.2024.01.042openalex-snapshot
Past, present, and future of CRISPR genome editing technologies
inferred← citeshttps://doi.org/10.1016/j.cis.2025.103497openalex-snapshot
Comprehensive strategies for constructing efficient CRISPR/Cas based cancer therapy: Target gene selection, sgRNA optimization, delivery methods and evaluation
inferred← citeshttps://doi.org/10.1016/j.cobme.2023.100509openalex-snapshot
The changing landscape of gene editing tool delivery in neurological disorders
inferred← citeshttps://doi.org/10.1016/j.colsurfa.2025.138287openalex-snapshot
Charge-engineered lipid nanoparticles with poly (γ-glutamic acid) for improved CRISPR/Cas9 genome editing
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2021.112257openalex-snapshot
Tumor microenvironment based stimuli-responsive CRISPR/Cas delivery systems: A viable platform for interventional approaches
inferred← citeshttps://doi.org/10.1016/j.copbio.2021.07.007openalex-snapshot
Accelerating vein-to-vein cell therapy workflows with new bioanalytical strategies
inferred← citeshttps://doi.org/10.1016/j.crbiot.2026.100382openalex-snapshot
CRISPR/Cas9 in cancer research and therapeutics: Clinical applications, optimization strategies, and future perspectives
inferred← citeshttps://doi.org/10.1016/j.ctarc.2026.101341openalex-snapshot
CRISPR-Cas9 gene editing approaches in colorectal cancer: Current progress and future prospects
inferred← citeshttps://doi.org/10.1016/j.dmpk.2022.100450openalex-snapshot
Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.103375openalex-snapshot
CRISPR/Cas9 in the era of nanomedicine and synthetic biology
inferred← citeshttps://doi.org/10.1016/j.ejpb.2024.114203openalex-snapshot
Recent trends in the delivery of RNA drugs: Beyond the liver, more than vaccine
inferred← citeshttps://doi.org/10.1016/j.ejpb.2024.114222openalex-snapshot
Kinetics of RNA-LNP delivery and protein expression
inferred← citeshttps://doi.org/10.1016/j.envres.2023.116333openalex-snapshot
Natural components as surface engineering agents for CRISPR delivery
inferred← citeshttps://doi.org/10.1016/j.envres.2023.116573openalex-snapshot
Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics
inferred← citeshttps://doi.org/10.1016/j.eurpolymj.2025.114001openalex-snapshot
Liposome-mediated anticancer drug delivery strategies for advancing brain tumor therapy
showing the first 200 of 609
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.